ASX:4DX 4DMedical (4DX) Stock Price, News & Analysis → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free 4DX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 4DMedical alerts: Email Address Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About 4DMedical Stock (ASX:4DX)4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.Read More Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! 4DX Stock News HeadlinesMarch 7, 2024 | finance.yahoo.comHere's Why We're Watching 4DMedical's (ASX:4DX) Cash Burn SituationMarch 5, 2024 | fool.com.auThis ASX healthcare stock is up 12% in 2 days since All Ords inclusion: Should you buy?April 24, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… January 21, 2024 | msn.comASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, PhilipsDecember 11, 2023 | msn.com4D Medical signs agreement to acquire Imbio in USDecember 6, 2023 | finance.yahoo.com4DMedical Limited (ASX:4DX): Is Breakeven Near?November 20, 2023 | msn.comASX Health Stocks: 4DX jumps 15pc after FDA clearanceNovember 19, 2023 | msn.comASX Health Stocks: 4DX jumps 15pc after FDA clearance; AI-focused biotechs TrivarX and Artrya also gainApril 24, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… November 13, 2023 | fool.com.auThis ASX medtech stock is roaring 67% higher today on a US approvalOctober 26, 2023 | finance.yahoo.comShareholders May Be More Conservative With 4DMedical Limited's (ASX:4DX) CEO Compensation For NowAugust 30, 2023 | finance.yahoo.com4DMedical Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagAugust 30, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of 4DMedical Limited (ASX:4DX)July 20, 2023 | fool.com.auBell Potter rates these small cap ASX shares as buysJuly 5, 2023 | finance.yahoo.comHere's Why We're Not At All Concerned With 4DMedical's (ASX:4DX) Cash Burn SituationMay 3, 2023 | msn.comGuess which ASX medical share has exploded 275% in a month?April 9, 2023 | afr.com‘We can play in big league’: 4D Medical rockets on US contractApril 6, 2023 | finance.yahoo.comRetail investors are 4DMedical Limited's (ASX:4DX) biggest owners and were rewarded after market cap rose by AU$65m last weekApril 5, 2023 | msn.comGuess which ASX healthcare share is rocketing 67% on a US hospital dealJanuary 26, 2023 | finance.yahoo.comWe Think 4DMedical (ASX:4DX) Needs To Drive Business Growth CarefullyNovember 28, 2022 | finance.yahoo.com4DMedical Limited (4DX.AX)September 1, 2022 | finance.yahoo.comVanderbilt Completes Study Evaluating Advanced, Four-Dimensional Lung Imaging Software from 4DMedicalAugust 23, 2022 | fool.com.auWhy has the 4D Medical share price popped 7% in a month?August 23, 2022 | fool.com.au4DMedical share price volatile as rising costs offset increased incomeAugust 18, 2022 | finance.yahoo.comHere's Why We're Not Too Worried About 4DMedical's (ASX:4DX) Cash Burn SituationJuly 22, 2022 | markets.businessinsider.com4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 AppropriationsJune 27, 2022 | fool.com.auWhy is the 4DMedical share price exploding 40% today?See More Headlines Receive 4DX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4DMedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:4DX CUSIPN/A CIKN/A Webwww.4dmedical.com Phone61 3 9545 5940FaxN/AEmployees131Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,830,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-45.83% Return on Assets-27.40% Debt Debt-to-Equity Ratio5.00 Current Ratio1.82 Quick Ratio6.01 Sales & Book Value Annual Sales$1.03 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.23 per share Price / BookN/AMiscellaneous Outstanding Shares391,090,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.31 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Andreas Fouras M.A.I.C.D.Ph.D., Founder, MD, CEO & DirectorMr. Simon GloverChief Financial OfficerMr. John Andrew Livingston BAppSciGradCertBus, GradDipHSc, Executive DirectorMs. Naomi LawrieCompany Secretary & General CounselMs. Rachael TenkatenChief of StaffDr. Aidan Jamison B.E.Ph.D., Senior Vice President of EngineeringDr. Michael Curtis Ph.D.Chief Software ArchitectDr. Jon Dusting Ph.D.Chief Research OfficerDr. Jason Kirkness Ph.D.Senior Vice President of Medical & Clinical AffairsMr. Matt TuckerChief Commercial OfficerMore ExecutivesKey CompetitorsAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTAnteris TechnologiesASX:AVRView All CompetitorsInsidersGeraldine McGintySold 40,000 sharesTotal: $29,000.00 ($0.73/share)Geraldine McGintySold 40,000 sharesTotal: $31,600.00 ($0.79/share)Andreas FourasSold 1,306,100 sharesTotal: $607,336.50 ($0.47/share) This page (ASX:4DX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe Greatest Bull Market in Crypto History…Weiss RatingsFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport SocietyNew York goes dark, then America.Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4DMedical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
